Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › TX › Wichita Falls › NPI 1023013448
Clinic

United Regional Health Care System INC

United Regional Health Care System INC was paid $21.06M by Medicaid between Jan 2019 and Dec 2024, across 163 billing codes. Its largest line is 99285, emergency room visit (most serious) — 37% of everything it billed.

33Billing provider infoUNITED REGIONAL HEALTH CARE SYSTEM INC
WICHITA FALLS, TX 76301
33aNPI1023013448assigned 06/14/2005
33bProvider typeMulti-Specialty Clinic/Center
28Total paid$21.06M
24GClaims327,654
24DCodes billed163
24AFirst – last monthJan 2019 – Dec 2024
Compared with peers

Next to other Multi-Specialty Clinic/Center providers in Texas

Rank by total paid#3 of 86
Median peer was paid$191K
This provider vs. median111×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

$0$500K$1.0M2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
2019331$17K
20205,675$441K
2021101,186$4.59M
202293,681$5.79M
202377,048$6.44M
2024incomplete49,733$3.79M
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
99285 Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life 37% 18,311 16,992 $7.71M
99284 Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity 35% 22,348 21,264 $7.29M
41899 Unlisted procedure, dentoalveolar structures 4.1% 596 566 $854K
U0004 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r 3.3% 6,137 5,260 $697K
99283 Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity 2.9% 12,667 12,147 $613K
71045 Radiologic examination, chest; single view 2.9% 12,257 11,387 $609K
80053 Comprehensive metabolic panel 1.8% 31,603 25,964 $374K
85025 Blood count; complete (CBC), automated, and automated differential WBC count 1.7% 34,694 29,386 $349K
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe 1.3% 1,688 1,674 $270K
87636 Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B 1.3% 1,312 1,288 $266K
87651 Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe <1% 1,511 1,491 $177K
C9803 Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source <1% 7,639 7,323 $173K
151 more codes
99282 Emergency department visit for the evaluation and management, low to moderate severity <1% 3,043 $151K
U0005 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 <1% 4,148 $143K
0241U Neonatal screening for hereditary disorders, genomic sequence analysis panel <1% 2,285 $107K
93005 Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report <1% 4,946 $81K
96374 Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance <1% 7,904 $70K
96361 Intravenous infusion, hydration; each additional hour <1% 3,106 $65K
87880 Infectious agent antigen detection by immunoassay; Streptococcus, group A <1% 2,499 $65K
87804 Infectious agent antigen detection by immunoassay; Influenza, each type <1% 2,818 $60K
81514 <1% 179 $51K
70450 Computed tomography, head or brain; without contrast material <1% 1,475 $49K
0240U <1% 1,019 $47K
42820 Tonsillectomy and adenoidectomy; younger than age 12 <1% 14 $47K
87591 Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe <1% 715 $47K
87491 Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe <1% 715 $46K
87637 Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV <1% 185 $46K
74177 Computed tomography, abdomen and pelvis; with contrast material <1% 574 $43K
96375 Therapeutic injection; each additional sequential IV push <1% 4,317 $38K
87389 Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies <1% 730 $34K
81001 <1% 9,203 $33K
96365 Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour <1% 2,593 $33K
J7050 Infusion, normal saline solution, 250 cc <1% 6,105 $31K
87086 Culture, bacterial; quantitative colony count, urine <1% 4,642 $26K
84443 Thyroid stimulating hormone (TSH) <1% 3,836 $25K
87081 <1% 2,178 $23K
G0378 Hospital observation service, per hour <1% 505 $22K
84703 <1% 2,104 $18K
86780 <1% 684 $18K
84439 <1% 1,790 $14K
84484 <1% 3,150 $12K
J3490 Unclassified drugs <1% 2,082 $11K
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular <1% 1,812 $11K
81003 <1% 3,525 $10K
73630 <1% 191 $10K
83880 <1% 1,949 $9K
Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml <1% 1,066 $9K
83690 <1% 1,785 $8K
87420 <1% 420 $7K
72125 Computed tomography, cervical spine; without contrast material <1% 452 $7K
71046 Radiologic examination, chest; 2 views <1% 194 $7K
J1885 Injection, ketorolac tromethamine, per 15 mg <1% 2,398 $7K
87801 Infectious agent detection by nucleic acid; amplified probe, multiple organisms <1% 90 $7K
74176 Computed tomography, abdomen and pelvis; without contrast material <1% 188 $6K
0353U <1% 727 $6K
86850 <1% 985 $6K
J7030 Infusion, normal saline solution , 1000 cc <1% 2,005 $5K
82306 Vitamin D; 25 hydroxy, includes fraction(s), if performed <1% 665 $5K
83036 Hemoglobin; glycosylated (A1C) <1% 3,535 $5K
97110 Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion <1% 255 $5K
84702 <1% 519 $5K
G0463 Hospital outpatient clinic visit for assessment and management of a patient <1% 829 $5K
80306 <1% 799 $4K
11042 Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm <1% 90 $3K
80048 Basic metabolic panel (calcium, ionized) <1% 2,897 $3K
86803 <1% 125 $3K
J2405 Injection, ondansetron hydrochloride, per 1 mg <1% 3,442 $3K
85027 <1% 850 $3K
87088 <1% 1,463 $3K
87340 <1% 181 $3K
94640 Pressurized or nonpressurized inhalation treatment for acute airway obstruction <1% 363 $3K
84481 <1% 100 $3K
76801 <1% 31 $2K
80061 Lipid panel <1% 3,650 $2K
83735 <1% 1,741 $2K
85730 <1% 1,447 $2K
96366 Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour <1% 263 $2K
80076 <1% 174 $2K
81025 <1% 225 $2K
85610 <1% 2,400 $2K
86901 <1% 967 $2K
86900 <1% 928 $2K
77063 Screening digital breast tomosynthesis, bilateral <1% 307 $2K
J1100 Injection, dexamethasone sodium phosphate, 1 mg <1% 1,641 $1K
82565 <1% 325 $1K
87186 <1% 1,370 $1K
82607 <1% 834 $1K
86762 <1% 70 $1K
82803 <1% 215 $1K
80050 General health panel <1% 33 $1K
86140 <1% 1,282 $1K
82728 <1% 211 $1K
73560 <1% 222 $1K
J2270 Injection, morphine sulfate, up to 10 mg <1% 408 $1K
83605 <1% 327 $1K
J0696 Injection, ceftriaxone sodium, per 250 mg <1% 377 $970.56
87070 <1% 42 $925.95
82140 <1% 733 $854.10
80177 <1% 917 $826.21
J2272 Injection, morphine sulfate (fresenius kabi), not therapeutically equivalent to j2270, up to 10 mg <1% 420 $799.71
85652 <1% 1,506 $723.20
86800 <1% 16 $651.14
82550 <1% 470 $590.91
96360 Intravenous infusion, hydration; initial, 31 minutes to 1 hour <1% 304 $586.09
86376 <1% 16 $549.62
C1713 Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable) <1% 576 $518.83
82105 <1% 12 $517.70
77067 Screening mammography, bilateral, including computer-aided detection <1% 307 $444.16
87040 <1% 102 $427.74
82375 <1% 165 $398.72
82951 <1% 12 $359.32
80164 <1% 537 $343.18
82077 <1% 72 $332.09
84134 <1% 1,205 $314.88
84100 <1% 537 $298.67
96413 Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance <1% 19 $295.50
J3010 Injection, fentanyl citrate, 0.1 mg <1% 1,003 $272.90
A9270 Non-covered item or service <1% 3,076 $244.45
84460 <1% 13 $216.72
84450 <1% 13 $212.03
83050 <1% 99 $205.47
82330 <1% 188 $205.14
82040 <1% 13 $202.79
83721 <1% 213 $201.46
85379 <1% 116 $201.45
82950 <1% 15 $194.48
82947 <1% 536 $185.35
82962 <1% 3,515 $160.81
70551 Magnetic resonance imaging, brain; without contrast material <1% 12 $151.22
82570 <1% 208 $150.14
87641 <1% 37 $132.29
84145 <1% 45 $129.64
96376 <1% 34 $124.20
88305 Level IV - Surgical pathology, gross and microscopic examination <1% 25 $117.39
73030 <1% 69 $110.96
J2550 Injection, promethazine hcl, up to 50 mg <1% 116 $91.20
J7120 Ringers lactate infusion, up to 1000 cc <1% 956 $91.08
87210 <1% 13 $84.59
83540 <1% 104 $82.00
J2250 Injection, midazolam hydrochloride, per 1 mg <1% 345 $80.15
82150 <1% 43 $77.25
90686 <1% 36 $77.01
J2704 Injection, propofol, 10 mg <1% 814 $69.33
72100 <1% 28 $60.88
73610 <1% 13 $59.48
J2919 Injection, methylprednisolone sodium succinate, 5 mg <1% 15 $56.75
82043 <1% 68 $52.14
J1170 Injection, hydromorphone, up to 4 mg <1% 21 $43.03
36415 Collection of venous blood by venipuncture <1% 20,567 $40.74
84132 <1% 116 $38.52
82435 <1% 98 $35.45
J7040 Infusion, normal saline solution, sterile (500 ml = 1 unit) <1% 230 $32.22
84550 <1% 145 $29.32
J0690 Injection, cefazolin sodium, 500 mg <1% 73 $27.22
J7613 Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg <1% 15 $19.48
84295 <1% 26 $13.38
J1200 Injection, diphenhydramine hcl, up to 50 mg <1% 13 $5.26
G1004 Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program 0% 2,854 $0.00
A6212 Foam dressing, wound cover, sterile, pad size 16 sq. in. or less, with any size adhesive border, each dressing 0% 35 $0.00
82248 0% 12 $0.00
80185 0% 18 $0.00
G0008 Administration of influenza virus vaccine 0% 12 $0.00
94762 0% 15 $0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialEDMONDSON, CORY (PRESIDENT & CHIEF EXECUTIVE OFFICER)